Literature DB >> 7940825

Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.

M B Regazzi1, I Iacona, C Campana, A Gavazzi, M Viganò, G Perani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7940825

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres.

Authors:  K Sakamoto; H Mikami; J Kimura
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

Review 3.  Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.

Authors:  H Lennernäs; G Fager
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

Review 4.  Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients.

Authors:  Anders Asberg
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3.

Authors:  Savannah J McFeely; Tasha K Ritchie; Jingjing Yu; Anna Nordmark; René H Levy; Isabelle Ragueneau-Majlessi
Journal:  Clin Transl Sci       Date:  2019-03-12       Impact factor: 4.689

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.